Authors: Slayden, RA Barry, CE

Citation: Ra. Slayden et Ce. Barry, The genetics and biochemistry of isoniazid resistance in Mycobacterium tuberculosis, MICROBES IN, 2(6), 2000, pp. 659-669

Authors: Slayden, RA Lee, RE Barry, CE

Citation: Ra. Slayden et al., Isoniazid affects multiple components of the type II fatty acid synthase system of Mycobacterium tuberculosis, MOL MICROB, 38(3), 2000, pp. 514-525

Authors: Wang, L Slayden, RA Barry, CE Liu, J

Citation: L. Wang et al., Cell wall structure of a mutant of Mycobacterium smegmatis defective in the biosynthesis of mycolic acids, J BIOL CHEM, 275(10), 2000, pp. 7224-7229

Authors: Behr, MA Schroeder, BG Brinkman, JN Slayden, RA Barry, CE

Citation: Ma. Behr et al., A point mutation in the mma3 gene is responsible for impaired methoxymycolic acid production in Mycobacterium bovis BCG strains obtained after 1927, J BACT, 182(12), 2000, pp. 3394-3399

Authors: Barry, CE Slayden, RA Sampson, AE Lee, RE

Citation: Ce. Barry et al., Use of genomics and combinatorial chemistry in the development of new antimycobacterial drugs, BIOCH PHARM, 59(3), 2000, pp. 221-231